Search research articles
Contact Us
Filters
Showing results (41-50 of 82) with videos related to
Page
of 9
Sort By:
Cancers
|
August 26, 2023
Zoledronic Acid Prevents Bone Resorption Caused by the Combination of Radium-223, Abiraterone Acetate, and Prednisone in an Intratibial Prostate Cancer Mouse Model
Mari I Suominen, Matias Knuuttila, Birgitta Sjöholm, et al.
BJU International
|
September 6, 2017
Prospective randomised non-inferiority trial of pelvic drain placement vs no pelvic drain placement after robot-assisted radical prostatectomy
Avinash Chenam, Bertram Yuh, Ali Zhumkhawala, et al.
The Journal of Urology
|
May 15, 2013
Expressed prostatic secretion biomarkers improve stratification of NCCN active surveillance candidates: performance of secretion capacity and TMPRSS2:ERG models
Christopher Whelan, Mark Kawachi, David D Smith, et al.
Scientific Reports
|
November 7, 2018
A Randomized Control Trial Of Anti-Inflammatory Regional Hypothermia On Urinary Continence During Robot-Assisted Radical Prostatectomy
Linda M Huynh, Douglas Skarecky, James Porter, et al.
European Urology Oncology
|
August 15, 2019
Internal and External Validation of a 90-Day Percentage Erection Fullness Score Model Predicting Potency Recovery Following Robot-assisted Radical Prostatectomy
Linda M Huynh, Douglas Skarecky, Timothy Wilson, et al.
Journal of the American Academy of Dermatology
|
November 18, 2006
The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride
Elise A Olsen, Maria Hordinsky, David Whiting, et al.
The Journal of Dermatology
|
April 4, 2017
Understanding patient and physician perceptions of male androgenetic alopecia treatments in Asia-Pacific and Latin America
Zrinka Lulic, Shigeki Inui, Woo-Young Sim, et al.
World Journal of Urology
|
May 13, 2019
Impact of disease progression on individual IPSS trajectories and consequences of immediate versus delayed start of treatment in patients with moderate or severe LUTS associated with BPH
Salvatore D'Agate, Timothy Wilson, Burkay Adalig, et al.
European Urology
|
November 18, 2008
The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT study
Claus G Roehrborn, Paul Siami, Jack Barkin, et al.
British Journal of Clinical Pharmacology
|
March 8, 2020
Model-based meta-analysis of individual International Prostate Symptom Score trajectories in patients with benign prostatic hyperplasia with moderate or severe symptoms
Salvatore D'Agate, Timothy Wilson, Burkay Adalig, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 82) with videos related to
Sort By:
Page
of 9
Cancers
|
August 26, 2023
Zoledronic Acid Prevents Bone Resorption Caused by the Combination of Radium-223, Abiraterone Acetate, and Prednisone in an Intratibial Prostate Cancer Mouse Model
Mari I Suominen, Matias Knuuttila, Birgitta Sjöholm, et al.
BJU International
|
September 6, 2017
Prospective randomised non-inferiority trial of pelvic drain placement vs no pelvic drain placement after robot-assisted radical prostatectomy
Avinash Chenam, Bertram Yuh, Ali Zhumkhawala, et al.
The Journal of Urology
|
May 15, 2013
Expressed prostatic secretion biomarkers improve stratification of NCCN active surveillance candidates: performance of secretion capacity and TMPRSS2:ERG models
Christopher Whelan, Mark Kawachi, David D Smith, et al.
Scientific Reports
|
November 7, 2018
A Randomized Control Trial Of Anti-Inflammatory Regional Hypothermia On Urinary Continence During Robot-Assisted Radical Prostatectomy
Linda M Huynh, Douglas Skarecky, James Porter, et al.
European Urology Oncology
|
August 15, 2019
Internal and External Validation of a 90-Day Percentage Erection Fullness Score Model Predicting Potency Recovery Following Robot-assisted Radical Prostatectomy
Linda M Huynh, Douglas Skarecky, Timothy Wilson, et al.
Journal of the American Academy of Dermatology
|
November 18, 2006
The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride
Elise A Olsen, Maria Hordinsky, David Whiting, et al.
The Journal of Dermatology
|
April 4, 2017
Understanding patient and physician perceptions of male androgenetic alopecia treatments in Asia-Pacific and Latin America
Zrinka Lulic, Shigeki Inui, Woo-Young Sim, et al.
World Journal of Urology
|
May 13, 2019
Impact of disease progression on individual IPSS trajectories and consequences of immediate versus delayed start of treatment in patients with moderate or severe LUTS associated with BPH
Salvatore D'Agate, Timothy Wilson, Burkay Adalig, et al.
European Urology
|
November 18, 2008
The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT study
Claus G Roehrborn, Paul Siami, Jack Barkin, et al.
British Journal of Clinical Pharmacology
|
March 8, 2020
Model-based meta-analysis of individual International Prostate Symptom Score trajectories in patients with benign prostatic hyperplasia with moderate or severe symptoms
Salvatore D'Agate, Timothy Wilson, Burkay Adalig, et al.
Page
of 9